SGRY Stock Recent News

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and SGRY are set to gain the most.

Surgery Partners (SGRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SGRY, DFH, CDRE, DHI and KB have been added to the Zacks Rank #1 (Strong Buy) List on August 15, 2023.

Although the revenue and EPS for Surgery Partners (SGRY) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Surgery Partners (SGRY) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.03 per share a year ago.

BRENTWOOD, Tenn., July 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2023 results before the market opens on Tuesday, August 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time)

Surgery Partners comes with a set of attractive investment criteria. SGRY's economic characteristics, such as a consistent stream of 20% returns on existing capital, are standout features in the debate. A revised growth outlook and attractive valuation support a buy rating with a $62.50 price target.

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jason Cassorla - Citi Nabil Gutierrez - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Whit Mayo - SVB Securities Bill Sutherland - The Benchmark Company Stephen Valiquette - Barclays Operator Greetings, and welcome to the Surgery Partners First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode.

Surgery Partners (SGRY) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.09 per share a year ago.